Skip to main content
SpringerLink
Log in

Bronchospasmolytika und Antiasthmatika

  • Chapter
  • First Online:
Arzneiverordnungs-Report 2020

  • 2981 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 69.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 89.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

Literatur

  • Alagha K, Palot A, Sofalvi T, Pahus L, Goultra M, Tummino C, Martinez S, Charpin D, Bourdin A, Chanez P (2014) Long-acting muscarinic antagonists for the treatment of chronic airway diseases. Ther Adv Chronic Dis 5:85–98

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Arzneimittelkommission der deutschen Ärzteschaft (2019) AkdÄ Drug Safety Mail 59-2019

    Google Scholar 

  • Barnes PJ (2008) Immunology of asthma and chronic obstructive pulmonary disease. Nat Rev Immunol 8:183–192

    Article  CAS  PubMed  Google Scholar 

  • Barnes PJ (2015) Therapeutic approaches to asthma-chronic obstructive pulmonary disease overlap syndromes. J Allergy Clin Immunol 136:531–545

    Article  PubMed  Google Scholar 

  • Befekadu E, Onofrei C, Collice GL (2014) Tiotropium in asthma: a systematic review. J Asthma Allergy 7:11–21

    PubMed  PubMed Central  Google Scholar 

  • Brand PL (2011) Inhaled corticosteroids should be the first line of treatment for children with asthma. Paediatr Respir Rev 12:245–249

    Article  PubMed  Google Scholar 

  • Buhl R, Bals R, Baur X, Berdel D, Criée C-P, Gappa M et al (2017) S2k-Leitlinie zur Diagnostik und Therapie von Patienten mit Asthma. http://www.awmf.org/uploads/tx_szleitlinien/020-009l_S2k_Asthma_Diagnostik_Therapie_2017-11_1.pdf (WMF-Registernummer 020-009)

  • Bundesärztekammer (BÄK), Kassenärztliche Bundesvereinigung (KBV), Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF) (2018) Nationale VersorgungsLeitlinie Asthma – Langfassung, 3. Aufl. https://doi.org/10.6101/AZQ/000400 (Version 1, www.asthma.versorgungsleitlinien.de)

    Book  Google Scholar 

  • Bundesministerium für Gesundheit (2016a) Bekanntmachung eines Beschlusses des Gemeinsamen Bundesausschusses über eine Änderung der Arzneimittel-Richtlinie (AM-RL) (Anlage XII – Beschlüsse über die Nutzenbewertung von Arzneimitteln mit neuen Wirkstoffen nach § 35a des Fünften Buches Sozialgesetzbuch (SGB V) Aclidiniumbromid vom 7. Apr. 2016 veröffentlicht am 7. April 2016, BAnz AT 3. Mai 2016 B3)

    Google Scholar 

  • Bundesministerium für Gesundheit (2016b) Bekanntmachung eines Beschlusses des Gemeinsamen Bundesausschusses über eine Änderung der Arzneimittel-Richtlinie (AM-RL) (Anlage XII – Beschlüsse über die Nutzenbewertung von Arzneimitteln mit neuen Wirkstoffen nach § 35a des Fünften Buches Sozialgesetzbuch (SGB V) Umeclidinium vom 21. Juli 2016 veröffentlicht am 11. August 2016, BAnz AT 11. Aug. 2016 B4)

    Google Scholar 

  • Chauhan BF, Chartrand C, Ducharme FM (2013a) Intermittent versus daily inhaled corticosteroids for persistent asthma in children and adults. Cochrane Database Syst Rev 2:CD9611

    Google Scholar 

  • Chauhan BF, Salah BR, Ducharme FM (2013b) Addition of anti-leukotriene agents to inhaled cortocosteroids in children with persisten asthma. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858

    Article  PubMed  Google Scholar 

  • Chung KF, Wenzel SE, Brozek JL, Bush A, Castro M, Sterk PJ, Adcock IM, Bateman ED, Bel EH, Bleecker ER, Boulet LP, Brightling C, Chanez P, Dahlen SE, Djukanovic R, Frey U, Gaga M, Gibson P, Hamid Q, Jajour NN, Mauad T, Sorkness RL, Teague WG (2014) International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma. Eur Respir J 43:343–373

    Article  CAS  PubMed  Google Scholar 

  • Cingi C, Mulik NB, Ipci K, Sahin E (2015) Antileukotrienes in upper airway inflammatory disease. Curr Allergy Asthma Rep 15:64. https://doi.org/10.1007/s11882-015-0564-7

    Article  CAS  PubMed  Google Scholar 

  • Fabbri LM, Calverley PM, Izquierdo-Alonso JL, Bundschuh DS, Brose M, Martinez FJ, Rabe KF, M2-127 and M2-128 study groups (2009) Roflumilast in moderate-to-severe chronic obstructive pulmonary disease treated with longacting bronchodilators: two randomised clinical trials. Lancet 374:695–703

    Article  CAS  PubMed  Google Scholar 

  • Fajt ML, Wenzel SE (2017) Development of new therapies for severe asthma. Allergy Asthma Immunol Res 9:3–14

    Article  CAS  PubMed  Google Scholar 

  • FDA Drug Safety Communbication (2017) FDA review finds no significant increase in risk of serious asthma outcomes with long-acting beta agonists (LABAs) used in combination with inhaled corticosteroids (ICS). https://www.fda.gov/downloads/Drugs/DrugSafety/UCM589997.pdf

  • Fuhlbrigge AL, Kelly HW (2014) Inhaled corticosteroids in children: effects on bone mineral density and growth. Lancet Respir Med 2:487–496

    Article  CAS  PubMed  Google Scholar 

  • Gibson PG, McDonald VM (2015) Asthma-COPD overlap 2015: now were are six. Thorax 70:683–691

    Article  PubMed  Google Scholar 

  • Global Initiative for Chronic Obstructive Lung Disease (GOLD) (2017) GOLD 2017 Global Strategy for the Diagnosis, Management and Prevention of COPD. http://www.goldcopd.org

  • Haasler I, Buhl R, Taube C (2011) Asthma bronchiale: neue Erkenntnisse und Entwicklungen. Dtsch Med Wochenschr 136:198–200

    Article  CAS  PubMed  Google Scholar 

  • Hines KL, Peebles RS (2017) Management of the asthma-COPD overlap syndrome (ACOS): a review of the evidence. Curr Allergy Asthma Rep. https://doi.org/10.1007/s11882-017-0683-4

    Article  PubMed  Google Scholar 

  • Hizawa N (2016) Clinical approaches towards asthma and chronic obstructive pulmonary disease based on the heterogeneity of disease pathogenesis. Clin Exp Allergy 46:679–687

    Article  Google Scholar 

  • Janjua S, Fortescue R, Poole P (2020) Phosphodiesterase-4 inhibitors for chronic obstructive pulmonary disease. Cochrane Database Syst Rev 5(5):CD2309. https://doi.org/10.1002/14651858.CD002309.pub6

    Article  PubMed  Google Scholar 

  • Kirsch F, Teuner CM, Menn P, Leidl R (2013) Krankheitskosten für Asthma und COPD bei Erwachsenen in der Bundesrepublik Deutschland. Gesundheitswesen 75:413–423

    Article  CAS  PubMed  Google Scholar 

  • Küpper T, Goebbels K, Kennes LN, Netzer NC (2012) Cromoglycate, reproterol, or both – what’s best for exercise-induced asthma? Sleep Breath 16:1229–1235

    Article  PubMed  Google Scholar 

  • Lange P, Halpin DM, O’Donnell DE, MacNee W (2016) Diagnosis assessment, and phenotyping of COPD: beyond FEV1. Int J Copd 11:3–12

    CAS  Google Scholar 

  • Matera MG, Calzetta L, Rinaldi B, Cazzola M (2017) Pharmacokinetic/pharmacodynamic Drug Evaluation of Benralizumab for the treatment of Asthma. Expert Opin Drug Metab Toxicol 13:1007–1013

    Article  CAS  PubMed  Google Scholar 

  • McNicholas WT (2017) COPD-OSA overlap syndrome: evolving evidence regarding epidemioloygy, clinical consequence, and management. Chest. https://doi.org/10.1016/j.chest.2017.04.160

    Article  PubMed  Google Scholar 

  • National Heart Lung and Blood Institute (2007) Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma. Full Report 2007. NIH Publication No 07-4051 2007. https://www.nhlbi.nih.gov/health-topics/guidelines-for-diagnosis-management-of-asthma

  • Ngkelo A, Adcock IM (2013) New Treatment for COPD. Curr Opin Pharmacol 13:1–8

    Article  Google Scholar 

  • Normansell R, Walker S, Milan SJ, Walters E, Nair P (2014) Omazilumab for chronoc asthma in adults and children. Cochrane Collab. https://doi.org/10.1002/14651858.CD003559.pub4

    Article  Google Scholar 

  • Pavord ID, Korn S, Howarth P, Bleecker ER, Buhl R, Keene ON, Ortega H, Chanez P (2012) Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial. Lancet 380:651–659

    Article  CAS  PubMed  Google Scholar 

  • Pedersen S (2006) Clinical safty of inhaled corticosteroids for asthma in children – an update of long-term trials. Drug Saf 29:599–612

    Article  CAS  PubMed  Google Scholar 

  • Rank MA, Hagan JB, Park MA, Podjasek JC, Samant SA, Volcheck GW, Erwin PJ, West CP (2013) The risk of asthma exacerbation after stopping low-dose inhaled corticosteroids: A systematic review and meta-analysis of randomized controlled trials. J Allergy Clin Immunol 131:724–729

    Article  CAS  PubMed  Google Scholar 

  • Reddel HK, FitzGerald JM, Bateman ED, Bacharier LB, Becker A, Brusselle G et al (2019) GINA 2019: a fundamental change in asthma management. Eur Respir J 53:1901046

    Article  PubMed  Google Scholar 

  • Rennard SI, Drummond MB (2015) Early chronic obstructive pulmonary disease: definition, assessment, and prevention. Lancet 385:1778–1788

    Article  PubMed  PubMed Central  Google Scholar 

  • Rodrigo GJ, Castro-Rodriguez JA, Nannini LJ, Plaza Moral V, Schiavi EA (2009) Tiotropium and risk for fatal and nonfatal cardiovascular events in patients with chronic obstructive pulmonary disease: a systematic review with meta-analysis. Respir Med 103:1421–1429

    Article  PubMed  Google Scholar 

  • Singh S, Loke YK, Furberg CD (2008) Inhaled anticholinergics and risk of major adverse cardiovascular events in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis. JAMA 300:1439–1450

    Article  CAS  PubMed  Google Scholar 

  • Smolensky M, Lemmer B, Reinberg A (2007) chronobiology and chronotherapy of allergic rhinitis and bronchial asthma. Adv Drug Del Rev 59:852–882

    Article  CAS  Google Scholar 

  • Tashkin DP, Celli B, Senn S, Burkhadt D, Kesten S, Menjoge S, Decramer M (2008) A 4-year trial of tiotropium in chronic pulmonary disease. N Engl J Med 359:1543–1554

    Article  CAS  PubMed  Google Scholar 

  • Tashkin DP, Celli BR, Decramer M, Lystig T, Liu D, Kesten S (2012) Efficacy of tiotropium in COPD patients with FEV1 ≥ 60% participating in the UPLIFT® trial. J Chronic Obstr Pulm Dis 9:289–296

    Article  Google Scholar 

  • Vogelmeier C, Buhl R, Burghuber O, Criée C-P, Ewig S, Godnic-Cvar J et al (2018) Leitlinie zur Diagnostik und Therapie von Patienten mit chronisch obstruktiver Bronchitis und Lungenemphysem (COPD). Pneumonogie 72:253–308

    CAS  Google Scholar 

  • Watts KL, Chavasse RJ (2012) Leukotriene receptor antagonists in addition to usual care for acute asthma in adults and children. Cochrane Database Syst Rev 5:CD6100

    Google Scholar 

  • Woodruff PG, Augusti A, Roche N, Singh D, Martinez FJ (2015) Current concepts in targeting chronic obstructive pulmonary disease pharmacotherapy: making progress towards personalised management. Lancet 385:1789–1798

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Zeppelinallee 33, 60325, Frankfurt, Deutschland

    Prof. Dr. med. Dr. h.c. Björn Lemmer

Authors
  1. Prof. Dr. med. Dr. h.c. Björn Lemmer
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Björn Lemmer .

Editor information

Editors and Affiliations

  1. Pharmakologisches Institut, Universität Heidelberg, Heidelberg, Baden-Württemberg, Germany

    Ulrich Schwabe

  2. Arzneimittelkommission der deutschen Ärzteschaft, Berlin, Berlin, Germany

    Wolf-Dieter Ludwig

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Der/die Herausgeber bzw. der/die Autor(en), exklusiv lizenziert durch Springer-Verlag GmbH, DE, ein Teil von Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Lemmer, B. (2020). Bronchospasmolytika und Antiasthmatika. In: Schwabe, U., Ludwig, WD. (eds) Arzneiverordnungs-Report 2020. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-62168-4_20

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-62168-4_20

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-62167-7

  • Online ISBN: 978-3-662-62168-4

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation